Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma

被引：0
|
作者：
Snehalatha Diddi
Swarna Bale
Gauthami Pulivendala
Chandraiah Godugu
机构：
[1] National Institute of Pharmaceutical Education and Research (NIPER),Department of Regulatory Toxicology
来源：
Inflammopharmacology | 2019年 / 27卷
关键词：
Scleroderma; Nimbolide; Bleomycin; EMT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：139 / 149
页数：10
相关论文
共 50 条
  • [1] Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma
    Diddi, Snehalatha
    Bale, Swarna
    Pulivendala, Gauthami
    Godugu, Chandraiah
    INFLAMMOPHARMACOLOGY, 2019, 27 (01) : 139 - 149
  • [2] Octreotide ameliorates dermal fibrosis in bleomycin-induced scleroderma
    Oyucu Orhan, Sibel
    Tektemur, Ahmet
    Gozel, Nevzat
    Ozercan, Ibrahim Hanifi
    Yolbas, Servet
    Yildirim, Ahmet
    Onalan, Ebru
    Koca, Suleyman Serdar
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (04) : 886 - 891
  • [3] Formyl Peptide Receptor 2 Activation Ameliorates Dermal Fibrosis and Inflammation in Bleomycin-Induced Scleroderma
    Park, Gyu Tae
    Kwon, Yang Woo
    Lee, Tae Wook
    Kwon, Seong Gyu
    Ko, Hyun-Chang
    Kim, Moon Bum
    Kim, Jae Ho
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [4] Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma
    Park, Gyu-Tae
    Yoon, Jung-Won
    Yoo, Sang-Bin
    Song, Young-Chul
    Song, Parkyong
    Kim, Hyoung-Kyu
    Han, Jin
    Bae, Sung-Jin
    Ha, Ki-Tae
    Mishchenko, Natalia P.
    Fedoreyev, Sergey A.
    Stonik, Valentin A.
    Kim, Moon-Bum
    Kim, Jae-Ho
    MARINE DRUGS, 2021, 19 (05)
  • [5] Genistein protects dermal fibrosis in bleomycin-induced experimental scleroderma
    Koca, Suleyman Serdar
    Dagli, Adile Ferda
    Yolbas, Servet
    Gozel, Nevzat
    Isik, Ahmet
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2015, 2 (03)
  • [6] RITUXIMAB AMELIORATES SKIN FIBROSIS THROUGH REGULATING MYOFIBROBLASTIC ACTIVITY AND TGF-β1 DIFFERENTIATION IN BLEOMYCIN-INDUCED EXPERIMENTAL SCLERODERMA MODEL
    Karatas, Ahmet
    Dik, Yavuz
    Ozgen, Metin
    Oz, Burak
    Onalan, Erhan
    Gozel, Nevzat
    Ustundag, Bilal
    Ozercan, Ibrahim H.
    Isik, Ahmet
    Koca, Suleyman S.
    FRESENIUS ENVIRONMENTAL BULLETIN, 2021, 30 (06): : 5645 - 5650
  • [7] Effectiveness of etanercept in bleomycin-induced experimental scleroderma
    Koca, S. S.
    Isik, A.
    Ozercan, I. H.
    Ustundag, B.
    Evren, B.
    Metin, K.
    RHEUMATOLOGY, 2008, 47 (02) : 172 - 175
  • [8] Dangui Huoxue Preparation (DHP) Ameliorates Skin Fibrosis, Inflammation, and Vasculopathy in the Bleomycin-Induced Murine Model of Systemic Sclerosis
    Yan, Yuemei
    Cao, Dianyu
    Liang, Jian
    Yang, Qiaorong
    Gao, Di
    Shen, Chen
    Hu, Feifei
    Li, Zheng
    Han, Yumei
    Cao, Xin
    Wang, Qiang
    ADVANCED BIOLOGY, 2024, 8 (01):
  • [9] Chlorogenic Acid Alleviates Inflammation and Fibrosis in a Murine Model of Bleomycin-Induced Systemic Sclerosis: A Histological Analysis
    Velazquez-Enriquez, Juan Manuel
    Mendoza-Crisostomo, Roxana Clarivel
    Reyes-Jimenez, Edilburga
    Santos-alvarez, Jovito Cesar
    Ramirez-Hernandez, Alma Aurora
    Gonzalez-Garcia, Karina
    Arellanes-Robledo, Jaime
    Vasquez-Garzon, Veronica Rocio
    Baltierrez-Hoyos, Rafael
    FUTURE PHARMACOLOGY, 2024, 4 (04): : 788 - 800
  • [10] Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma
    Matsushita, M
    Yamamoto, T
    Nishioka, K
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2004, 135 (04) : 348 - 356
12345